Ipsilateral herpes zoster after the first dose of BNT162b2 mRNA COVID‐19 vaccine

Abstract

As vaccination campaign against SARS-CoV-2 is on-going worldwide, dermatologists are witnessing an increasing number of cutaneous adverse events. Delayed hypersensitivity reactions at the site of injections with mRNA-1273 (Moderna) [1] and BNT162b2 (Pfizer-BioNtech) vaccines [2] are now known as COVID-arms .